Physician-led Pi Health has demonstrated capabilities to dramatically reduce clinical trial timelines and administrative burden, while increasing data quality
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
The Phase Ib MAD study is a randomized, double-blind, placebo-controlled trial conducted in the United States
Includes new $1.2 billion investment in manufacturing facilities, AI and advanced digital technologies, creating hundreds of highly skilled U.S. jobs
Ascletis announces ultra-long-acting subcutaneous depot maintenance formulation of small molecule GLP-1R agonist ASC30 with 75-Day observed half-life in participants with obesity
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
Targeting a 10% reduction in energy and water consumption, and a 30% cut in carbon emissions across facilities by 2025
He has been associated with the Zydus Group since 2009
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
Subscribe To Our Newsletter & Stay Updated
